Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Neurofibroma
Closed
Phase 3
This trial is looking at how well selumetinib might work for plexiform neurofibromas.
Plexiform neurofibromas are not cancer but are a growth on the nerves.
This trial is open to people with type 1 (NF1) who have plexiform neurofibromas that are causing symptoms. And you can’t have surgery to remove them.
Recruitment start: 19 November 2021
Recruitment end: 21 April 2023
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Angela Swampillai
AstraZeneca
Last reviewed: 09 Nov 2024
CRUK internal database number: 18241
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
